Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients

Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients

(2010) M. Scartozzi et al.   ANNALS OF ONCOLOGY

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer

(2010)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

VEGF −460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma

(2010) M-H Chen et al.   PHARMACOGENOMICS JOURNAL

Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer

(2010) Torben Frøstrup Hansen et al.   VIRCHOWS ARCHIV

Angiogenesis and Lymphangiogenesis of Gastric Cancer

(2010) Yasuhiko Kitadai   Journal of Oncology

Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6

(2009) Rui Zhao et al.   CANCER LETTERS

Influence of theVEGF-A936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer

(2009) Jean-Louis Formento et al.   PHARMACOGENOMICS

Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms

(2008) M. Kodama et al.   CLINICAL CANCER RESEARCH

Locoregional treatment of peritoneal carcinomatosis from gastric cancer

(2008) F. Bozzetti et al.   JOURNAL OF SURGICAL ONCOLOGY

Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment

(2008) Wim P Ceelen et al.   LANCET ONCOLOGY